P37 High-resolution nerve ultrasound to distinguish chronic inflammatory demyelinating polyneuropathy from axonal polyneuropathies

History-taking and nerve conduction studies are fundamental for the diagnosis and assessment of the severity of acute (AIDP) or chronic inflammatory demyelinating polyneuropathy (CIDP). The diagnostic challenge of distinguishing these two immune-mediated subacute polyradiculoneuropathies remains high, as intravenous immunoglobulin and steroids exert short-term clinical improvement in the majority of the CIDP cases, whereas steroids have no effect on AIDP patients. Accordingly, the precise classification of subacute polyradiculoneuropathies significantly affects the early application of steroids in CIDP. This review aims to give a timely update on the application of clinical, electrophysiological and nerve ultrasound parameters in distinguishing subacute CIDP from AIDP.

Download Full-text

PS01.004: UTILIZATION OF HIGH RESOLUTION IMPEDANCE MANOMETRY FOR LIVER TRANSPLANTATION PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY AND DYSPHAGIA

Diseases of the Esophagus ◽

10.1093/dote/doy089.ps01.004 ◽

2018 ◽

Vol 31 (Supplement_1) ◽

pp. 50-51

Author(s):

Hsu-Kai Huang

Keyword(s):

Liver Transplantation ◽

Weight Loss ◽

Body Weight ◽

High Resolution ◽

Muscle Weakness ◽

Conflicts Of Interest ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Body Weight Loss ◽

Demyelinating Polyneuropathy ◽

Inflammatory Demyelinating Polyneuropathy

Abstract Background Chronic inflammatory demyelinating polyneuropathy(CIDP) is a rare problem in liver transplantation recipients. We observed three patients with slowly progressive muscle weakness and dysphagia with body weight loss. Methods We describe the clinical features and high resolution impedance manometry(HRiM) results of 3 patients with liver transplantation who developed CIDP. Two patients had orthotopic liver transplantation and the other had living-donor liver transplantation. Results All 3 patients developed muscle weakness, dysphagia and body weight loss in the period of tapering immune suppressants. Diagnosis of CIDP were checked by neurologist consultation. All patients had immunosuppressive therapy with tacrolimus. Prednisolone in two cases and everolimus in one case were noted. Telbivudine treatment for chronic hepatitis B were given in all 3 patients. After HRiM evaluation, decreased functional oral intake scale(FOIS), distal contractile integral(DCI) and complete bolus rate were discovered. Plasma exchange were done and the follow up HRiM result showed obvious improved FOIS and DCI. Conclusion HRiM is a feasible and effective tool for evaluation of dysphagia in CIDP patients. This exam can be utilized before and after proper treatment. Disclosure All authors have declared no conflicts of interest.

Download Full-text

Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy

Journal of Neuroimaging ◽

10.1111/jon.12279 ◽

2015 ◽

Vol 25 (6) ◽

pp. 931-939 ◽

Cited By ~ 26

Author(s):

Antonios Kerasnoudis ◽

Kalliopi Pitarokoili ◽

Ralf Gold ◽

Min-Suk Yoon

Keyword(s):

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Therapy Monitoring ◽

Demyelinating Polyneuropathy ◽

Nerve Ultrasound ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text

Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy

Frontiers in Neurology ◽

10.3389/fneur.2021.632096 ◽

2021 ◽

Vol 12 ◽

Author(s):

Kang Du ◽

Ke Xu ◽

Si Cheng ◽

He Lv ◽

Wei Zhang ◽

...

Keyword(s):

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Compound Muscle Action Potential ◽

Familial Amyloid Polyneuropathy ◽

Demyelinating Polyneuropathy ◽

Lower Limbs ◽

Nerve Ultrasound ◽

Inflammatory Demyelinating Polyneuropathy ◽

Amyloid Polyneuropathy ◽

The Mean ◽

Transthyretin Familial Amyloid Polyneuropathy

Backgrounds: Transthyretin familial amyloid polyneuropathy (TTR-FAP) is frequently misdiagnosed as chronic inflammatory demyelinating polyneuropathy (CIDP) because of similar phenotypes in the two diseases. This study was intended to identify the role of nerve ultrasonography in evaluating TTR-FAP and CIDP.Methods: Eighteen patients with TTR-FAP, 13 patients with CIDP, and 14 healthy controls (HC) were enrolled in this study. Consecutive ultrasonography scanning was performed in six pairs of nerves of bilateral limbs with 30 sites. The cross-sectional areas (CSAs) and CSA variability data of different groups were calculated and compared.Results: Both TTR-FAP and CIDP showed larger CSAs at most sites of both upper and lower limbs than in HC groups. CIDP patients had larger CSAs than TTR-FAP patients at 8/15 of these sites, especially at U1-3, Sci2 sites (p < 0.01). However, the CSAs at above sites were not a credible index to differentiate TTR-FAP from CIDP with a low area under the curve (<0.8). The CSA variability of median nerves was significantly higher in CIDP than in TTR-FAP and HC groups, with high sensitivity (0.692) and specificity (0.833) to differentiate CIDP from TTR-FAP. The CSA variability of ulnar nerves was not significantly different between the three groups. For the TTR-FAP group, mean CSAs at each site were not correlated with different Coutinho stages, modified polyneuropathy disability, course of sensory motor peripheral neuropathy, Neuropathy Impairment Score, or Norfolk Quality of life-diabetic neuropathy score. The mean compound muscle action potential of ulnar nerves was negatively correlated with the mean CSAs of ulnar nerves.Interpretation: TTR-FAP patients had milder nerve enlargement with less variability in CSAs of median nerves than those with CIDP, suggesting that nerve ultrasound can be a potential useful auxiliary tool to help differentiate the two neuropathies.

Download Full-text